3B BlackBio Dx Ltd (3BBLACKBIO) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow 3B BlackBio Dx Ltd reported sales of ₹33.49 Cr, operating profit of ₹8.52 Cr (OPM 25.44%) and net profit of ₹8.98 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
3BBLACKBIO quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 29.15 25.39 22.5 22.23 33.9 50.35 35.43 33.49 Expenses 12.98 10.32 14.58 10.4 19.17 28.63 26.94 24.97 Operating Profit 16.17 15.07 7.92 11.83 14.73 21.72 8.49 8.52 OPM 55.47% 59.35% 35.2% 53.22% 43.45% 43.14% 23.96% 25.44% Other Income 3.44 3.01 4.94 4.32 5.51 5.59 10.15 6.14 Interest 0.03 0.02 0.04 0.01 0.04 0.09 0.1 0.1 Depreciation 0.27 0.27 0.28 0.28 0.58 0.38 3.89 1.34 Profit before tax 19.31 17.79 12.54 15.86 19.62 26.84 14.65 13.22 Tax 22.99% 24.17% 35.89% 20.3% 23.34% 16.39% 33.11% 32.07% Net Profit 14.87 13.49 8.04 12.65 15.04 22.44 9.81 8.98 EPS in Rs 17.07 15.61 9.79 14.67 17.14 25.32 11.14 11.1
3BBLACKBIO profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 81 62 74 96 142 153 Expenses 44 33 41 46 85 100 Operating Profit 37 29 33 50 57 53 OPM 46% 47% 44% 52% 40% 35% Other Income 7 7 13 15 26 27 Interest 0 0 0 0 0 0 Depreciation 1 1 1 1 5 6 Profit before tax 43 35 44 64 77 74 Tax 26% 27% 28% 25% 22% - Net Profit 32 26 32 48 60 56 EPS in Rs 42.89 34.55 37.4 55.57 68.27 64.7 Dividend Payout 24% 8% 8% 7% 7% -
3BBLACKBIO balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 9 9 9 9 9 Reserves 185 214 260 290 316 Borrowings 2 1 0 0 3 Other Liabilities 19 24 27 42 51 Total Liabilities 214 248 296 341 378 Fixed Assets 8 7 7 17 28 CWIP 0 0 0 0 0 Investments 92 117 156 160 158 Other Assets 114 123 132 163 193 Total Assets 214 248 296 341 378
3BBLACKBIO cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 37 20 27 43 52 Cash from Investing Activity -28 15 -20 -33 -24 Cash from Financing Activity -15 -5 -4 -3 -1 Net Cash Flow -6 30 3 7 28 Free Cash Flow 35 18 26 42 27 CFO/OP 129% 100% 115% 116% 121%
3BBLACKBIO ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 136 200 179 138 129 Inventory Days - 164 141 124 187 Days Payable - 69 66 28 70 Cash Conversion Cycle 136 296 253 235 245 Working Capital Days 162 241 215 169 143 ROCE 27% 19% 21% 26% 25%